Torti Frank bought ROIV

July 30, 2025 · Form 4 insider transaction

Torti Frank bought 1,836,547 shares of Roivant Sciences Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
1,836,547
Price
$0.00
Total value
N/A
RoleOfficer
SecurityCommon Shares
Transaction codeA: Grant or award
Transaction dateJuly 30, 2025
Filing dateAugust 1, 2025
Shares owned after1,836,547
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Reflects an award of restricted stock units with respect to Common Shares ("RSUs"), with a vesting commencement date of March 31, 2025, which service-vest (i) 20% on the first anniversary of the vesting commencement date and (ii) in 16 successive equal quarterly installments thereafter, subject to the reporting person's continuous service through each vesting date.

View the original Form 4 on SEC EDGAR